[1]
2022. Sodium-glucose Co-transporter 2 Inhibitors: A Novel Molecule for Health Care Practitioners in Diabetology, Cardiology and Nephrology. Indian Journal Of Clinical Practice. 33, 5 (Oct. 2022), 21–31.